Milad Abolhalaj

Milad Abolhalaj

Auto-generated profile, based on publicly available information

Milad Abolhalaj

Endocrinology and Metabolism Research Center (EMRC), Tehran University of Medical Sciences, Tehran 14114, Iran

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2011 in Endocrine
Verified
Journal Article
Closed access
PDF file
FAFarzaneh Abbasi
Farzaneh Abbasi
PAParvin Amiri
Parvin Amiri
FSForough A. Sayahpour
Forough A. Sayahpour
SPSaeed Pirmoradi
Saeed Pirmoradi
MAMilad Abolhalaj
Milad Abolhalaj
MAMahsa M. Amoli
Mahsa M. Amoli

4 December 2012 in Journal of Biomarkers
Verified
Journal Article
Open access
PDF file
MAMilad Abolhalaj
Milad Abolhalaj
MAMahsa M. Amoli
Mahsa M. Amoli
PAParvin Amiri
Parvin Amiri
Subject & Aim. Endothelial nitric oxide synthase (eNOS) is one of the most important candidate genes in CAD. A functional polymorphism within eNOS gene is a 27 bp VNTR on its intron 4 which has been shown to be associated with various diseases. In this study we investigated eNOS VNTR polymorphism in addition to eNOS gene expression profile in patients with CAD.Material and Methods. The study comprised patients with angiographically confirmed CAD (CAD+) and individuals with normal coronary as CAD−. eNOS VNTR polymorphism frequencies were determined in both groups. In addition eNOS gene expression profile was examined using a quantitative real-time PCR.Results. We have found that aa genotype was significantly increasing the risk of CAD in our patients (aa versus ab + bb, , ; 95% CI: = 0.98 to 16.2). The differences in eNOS expression were not significant between patients and normal group; however in CAD+patients eNOS expression was higher than the expression level of patients carrying other genotypes ().Conclusion. We have observed that eNOS gene polymorphism was associated with CAD in angiography-confirmed patients. However, the difference in eNOS gene expression was not statistically significant between patients and control which might be due to the contribution of other confounding factors which require further investigations.